References
- Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost 2009; 35: 189–203
- Everlien M, Knoch K, Farah I, Greve H. Coronary bypass surgery in May-Hegglin anomaly. Dtsch Med Wochenschr 2001; 126: 47–49
- Guibert Bayona MA, Borque Martin JL, Araujo Fernandez AM, Ruiz Ilundain G. Anesthesia in May-Hegglin anomaly. Rev Esp Anestesiol Reanim 2006; 53: 583–584
- Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJ, Briet E, Buller HR. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints. Lancet 1999; 354: 1940–1947
- Mahdy AM, Webster NR. Perioperative systemic haemostatic agents. Br J Anaesth 2004; 93: 842–858
- Fontaine E, Warwick R, Sastry P, Poullis M. Effect of foreign surface pacification with albumin, aprotinin, propofol, and high-density lipoprotein. J Extra Corpor Technol 2009; 41: 3–9
- Tsai CS, Hsu PC, Huang GS, Lin TC, Hong GJ, Shih CM, Li CY. Midazolam attenuates adenosine diphosphate-induced P-selectin expression and platelet-leucocyte aggregation. Eur J Anaesthesiol 2004; 21: 871–876
- Heller PG, Pecci A, Glembotsky AC, Savoia A, Negro FD, Balduini CL, Molinas FC. Unexplained recurrent venous thrombosis in a patient with MYH9-related disease. Platelets 2006; 17: 274–275